Before Mailing, register your DNA test kit at 23andMe online otherwise, your saliva sample will NOT be processed. 23andMe’s Health + Ancestry Service is the essential at-home DNA test kit with 100+ personalized reports. Get actionable genetic insights for your health, wellness, and heritage in one easy test. Listed in TIME’s Best Inventions Hall of Fame 2025.

Personalized Health Insights. Gain science-backed data to take proactive control of your well-being. Our service includes FDA-authorized reports to empower your health journey. Health Predispositions*: See your genetic risk for developing certain health conditions, including Type 2 Diabetes and Late-Onset Alzheimer’s Disease. Carrier Status*: Learn if you are a carrier for genetic variants linked to inherited conditions like Cystic Fibrosis—valuable information for family planning. Wellness Reports: Explore how your genes relate to lifestyle factors like Deep Sleep, Lactose Intolerance, and Genetic Weight.

Comprehensive Ancestry & Traits. Ancestry Composition: See your DNA breakdown across 4,500+ geographic regions worldwide—the most detailed view on the market. DNA Relatives: Opt-in to connect with living relatives and deepen your understanding of your family history and genealogy. Automatic Family Tree: Your family tree is instantly built from your DNA relationships, simplifying your lineage visualization. Haplogroups & Neanderthal: Trace your maternal and paternal lines back thousands of years and discover your Neanderthal ancestry. Traits Reports: Explore personalized insights on traits like hair curliness, freckles, and cilantro aversion.

Simple, Secure, and Private. Our DNA test is quick and easy—no blood or needles. Your DNA data is encrypted, protected, and under your control.

Upgrade Anytime: Easily upgrade in-app to 23andMe+ Premium for access to advanced health and ancestry features like Pharmacogenetics reports** (how your body may process certain medications), Health Action Plan, Historical Matches(SM), and ongoing new reports.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Visit 23andMe for important test information.

**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. Visit 23andMe for important Pharmacogenetics information.

† Based on 2019 online survey, designed by 23andMe and M/A/R/C Research, of approximately 1,000 23andMe Health + Ancestry customers.

Before you can use the 23andMe services and see your reports, you must agree to 23andMe's Terms of Service and 23andMe’s Privacy Statement at the time of registration of your 23andMe kit. For use in the USA only - kits shipped or used outside the US will be invalidated and no refund will be provided.